200,000+ products from a single source!
sales@angenechem.com
Home > Quinoline > 106798-52-1
CAS No: 106798-52-1 Catalog No: AG007TVP MDL No:
| Title | Journal |
|---|---|
| Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors. | Journal of medicinal chemistry 20150723 |
| A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia. | Leukemia 20111001 |
| The Traditional Japanese Medicine Rikkunshito Promotes Gastric Emptying via the Antagonistic Action of the 5-HT(3) Receptor Pathway in Rats. | Evidence-based complementary and alternative medicine : eCAM 20110101 |
| Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components. | Chinese medicine 20110101 |
| Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor. | British journal of cancer 20040419 |
| New targets for therapy in breast cancer: farnesyltransferase inhibitors. | Breast cancer research : BCR 20040101 |
| In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori. | The Journal of antimicrobial chemotherapy 20021001 |
| Quinoline 2-oxidoreductase and 2-oxo-1,2-dihydroquinoline 5,6-dioxygenase from Comamonas testosteroni 63. The first two enzymes in quinoline and 3-methylquinoline degradation. | European journal of biochemistry 19950901 |
| Microbial metabolism of quinoline and related compounds. XVII. Degradation of 3-methylquinoline by Comamonas testosteroni 63. | Biological chemistry Hoppe-Seyler 19930301 |
© 2019 Angene International Limited. All rights Reserved.